Alamar Biosciences Q3 2026: $33.5M Revenue Surge, UK Biobank & GSK Partnerships Power Proteomic Growth
Alamar Biosciences reports a 68% Q3 revenue jump to $33.5 M, powered by new UK Biobank and GSK partnerships that advance precision proteomics diagnostics.
2 minutes to read